Skip to main content
. 2018 Oct 31;9(23):4463–4476. doi: 10.7150/jca.26417

Figure 5.

Figure 5

Expression of miR-130b-3p, miR-19a-3p, miR-20a-5p, miR-106a-5p, miR-34a-5p, hsa-miR-195-5p, VEGFA, PHLPP2 and APP in samples from patients with BSGs. (A) Expression level of miR-130b-3p. (B) Expression level of miR-19a-3p. (C) Expression level of miR-20a-5p. (D) Expression level of miR-106a-5p. (E) Expression level of miR-34a-5p. (F) Expression level of miR-195-5p. (G) Expression level of VEGFA. (H) Expression level of PHLPP2. (I) Expression level of APP.